Saturday 17 October 2026 Export PBYI’s income statement to Excel — free account

Puma Biotechnology, Inc.

Puma Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $228.4 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 7.75%, EPS grew 33.3%, free cash flow fell 88.5% and total debt fell 79.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

9.83 0.69 −6.56%

Follow PBYI

Alert me

Market cap: $543.0M
P/E: 18.2×
Fwd P/E: 24.2×
Dividend yield: —
F-score: 8/9
Altman Z: −4.16
Beneish M: −2.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	8	7	7
ROE Full definition →		39.69%	27.97%	21.62%	21.97%
ROA Full definition →		17.46%	14.48%	12.54%	13.78%
ROIC Full definition →		39.95%	43.78%	51.10%	42.61%
Return on Tangible Assets Full definition →		60.46%	38.12%	29.50%	28.02%
Average Days of Receivables Full definition →		57.79	85.75	42.30	53.76
Free Cash Flow per Share Full definition →		0.85	0.83	1.05	0.81
Free Cash Flow Full definition →		42.87	41.73	53.61	41.15
Capital Expenditures Full definition →		(0.12)	(0.07)	—	—
Other line items
Cash ROIC Full definition →		17.46%	16.53%	22.03%	17.70%
Accounts Receivable Turnover Full definition →		4.81	5.33	8.82	7.71
Accounts Payable Turnover Full definition →		7.05	11.01	8.18	13.65
Inventory Turnover Full definition →		8.06	8.17	6.65	5.31
Average Days of Payables Full definition →		47.62	31.73	51.37	19.47
Days of Inventory on Hand Full definition →		70.66	34.61	54.68	83.56
Tax Rate Full definition →		0.20	(0.13)	(0.16)	(0.14)
Research and Development Expense of Revenue Full definition →		28.49%	27.18%	29.93%	30.90%
Selling, General and Administrative Expense of Revenue Full definition →		32.59%	31.02%	31.55%	30.78%
Share Based Compensation of Revenue Full definition →		3.34%	3.04%	3.00%	3.09%
Interest Coverage Full definition →		4.13	5.63	5.70	8.65
Operating CF/Net income Full definition →		1.16	1.34	2.20	1.54
Depreciation/Fixed assets Full definition →		36.47	58.49	86.50	101.74
Capex/Depreciation Full definition →		(0.01)	(0.01)	0.00	0.00
Revenue per Share Full definition →		4.21	4.57	4.47	4.54
Operating CF per Share Full definition →		0.85	0.84	1.05	0.81
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly